Get the Stockscreener App
10.00
0.00%
0.00
Oaktree Acquisition Corp Iii Life Sciences stock is traded at $10.00, with a volume of 113.48K.
It is up +0.00% in the last 24 hours and up +0.00% over the past month.
Oaktree Acquisition Corp III Life Sciences is a blank check company.
See More
Previous Close:
$10.00
Open:
$10
24h Volume:
113.48K
Relative Volume:
9.67
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$9.99
$10.01
1-Week Range:
$9.99
$10.02
52-Week Range:
$9.99
$10.02
Oaktree Acquisition Corp Iii Life Sciences Stock (OACCU) Company Profile
Name
Oaktree Acquisition Corp Iii Life Sciences
Sector
Industry
Phone
-
Address
-
Oaktree Acquisition Corp Iii Life Sciences Stock (OACCU) Latest News
White & Case advises underwriters on Oaktree Acquisition Corp. III Life Sciences’ US$175 million IPO - White & Case LLP
Spirit Aero losses deepen, burns cash as Boeing strike bites - Yahoo Canada Finance
IPO NewsUS IPO Weekly Recap: Standard Aero soars in 7-IPO week, while big tech names join pipeline - Renaissance Capital
The Aggregator: Envestnet approves Bain acquisition, Warburg Pincus leads $125m Series E - Alternatives Watch
Special Purpose Acquisition Companies - Ropes & Gray LLP
IRA Capital Acquires 237,000 Square-Foot Life Science/R&D Campus in Columbus - Newsfile
PE Weekly: Investment Bank Spins Out a New PE Firm - Middle Market Growth
Big M&A deals of 2023, From jerrycans to cheeseheads - Plastics News
Spotlight: Golden Triangle Offices & Laboratories - Savills
Redevelopment of Canary Wharf office building into life sciences space gets green light - BE News
Melissa Sawyer - Sullivan & Cromwell LLP
Chad D. Ehrenkranz - Sidley Austin LLP
Special Purpose Acquisition Company (SPAC) News and Analysis - SPACInsider
SPACs in Healthcare: The Hot Ticket has Cooled off - Managed Healthcare Executive
Direct Lending: Benefits, Risks and Opportunities - Oaktree Capital
A look back at the how tech changed the pharma landscape in 2020 - Mobihealth News
Axa IM acquires life sciences real estate developer Kadans - Funds Europe Magazine
Four IT companies merge to form digital powerhouse Avenga - Consultancy.eu
Silverpeak, Legacy, Oaktree Acquire Ohio Data Centers - Globe St.
Matthew S. Arenson, P.C. - Kirkland & Ellis LLP
Brookfield Asset Management (BAM) 10K Form and SEC Filings 2024 - MarketBeat
Global Healthcare Private Equity and Corporate M&A Report 2018 - Bain & Company
Oaktree Acquisition Corp Iii Life Sciences Stock (OACCU) Financials Data
There is no financial data for Oaktree Acquisition Corp Iii Life Sciences (OACCU). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.04%
0.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):